Arkolith/Insider Trading/ACRS/Form 4

Kolbeck Roland Wilhelm

Chief Scientific OfficerAclaris Therapeutics, Inc. (ACRS) · full profile →Form 4 · filed Aug 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2025Grant(A)146K—$0146K
Aug 1, 2025Grant(A)510K—$0510K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-021045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML